Daromun Component L19tnf
Daromun Component L19tnf Uses, Dosage, Side Effects, Food Interaction and all others data.
Daromun Component L19tnf is under investigation in clinical trial NCT02938299 (Neoadjuvant L19IL2/L19TNF- Pivotal Study).
| Trade Name | Daromun Component L19tnf |
| Generic | Onfekafusp alfa |
| Onfekafusp alfa Other Names | Daromun component l19tnf, Fibromun, Immunoglobulin, anti-(human fibronectin ed-b domain) (synthetic human clone l19 scfv fragment) fusion protein with human tumor necrosis factor .alpha., trimer, Onfekafusp alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Daromun Component L19tnf
